Lessons learned from acute myocardial infarction in patients with chronic kidney disease

Journal of Internal Medicine

Volumn 268, Issue 1, 2010, Pages 38-39

  McCullough, P A ^a   Verrill, T ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE HEART INFARCTION; ANGIOPLASTY; BLEEDING; BLOOD CLOT LYSIS; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS GRAFT; GLOMERULUS FILTRATION RATE; HEART PROTECTION; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY, CHRONIC;

EID: 77953524461     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02212.x     Document Type: Note

References (10)

1. Szummer K, Lundman P, Jacobsen SH et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome - data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) Register. J Int Med 2010 268 : 3 12.
2. Szummer K, Lundman P, Jacobsen SH et al. Influence on renal function on the effects of early revascularization in non ST-elevation myocardial infarction - data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 2009 120 : 851 858.
3. Skelding KA, Mehta LS, Pica MC et al. Primary percutaneous interventions for acute myocardial infarction in octogenarians: a single-center experience. Clin Cardiol 2002 25 : 363 366.
4. Rihal CS, Textor SC, Grill DE et al. Incicence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 : 2259 2264.
5. Yan AT, Yan RT, Huynh T et al. Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial. Am Heart J 2008 156 : 769 775.
6. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002 144 : 226 232.
7. Tokmakova MP, Skali H, Kenchaiah S et al. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation 2004 110 : 3667 3673.
8. McCullough PA, Rocher LR. Statin therapy in renal disease: harmful or protective. Curr Atheroscler Rep 2007 9 : 18 24.
9. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003 92 : 509 514.
10. Peterson PN, Ambardekar AV, Jones PG et al. Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies. BMC Cardiovasc Disord 2009 9 : 29.